Report of One-Year Prospective Surveillance of SARS-CoV-2 in Dogs and Cats in France with Various Exposure Risks: Confirmation of a Low Prevalence of Shedding, Detection and Complete Sequencing of an Alpha Variant in a Cat.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
03 09 2021
Historique:
received: 15 08 2021
revised: 24 08 2021
accepted: 25 08 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 14 10 2021
Statut: epublish

Résumé

Despite the probable zoonotic origin of SARS-CoV-2, only limited research efforts have been made to understand the role of companion animals in SARS-CoV-2 epidemiology. According to recent serological prevalence studies, human-to-companion animal transmission is quite frequent, which led us to consider that the risk of SARS-CoV-2 transmission from animal to human, albeit negligible in the present context, may have been underestimated. In this study, we provide the results of a prospective survey that was conducted to evaluate the SARS-CoV-2 isolation rate by qRT-PCR in dogs and cats with different exposure risks and clinical statuses. From April 2020 to April 2021, we analyzed 367 samples and investigated the presence of SARS-CoV-2 RNA using qRT-PCR. Only four animals tested positive, all of them being cats. Three cats were asymptomatic and one presented a coryza-like syndrome. We describe in detail the infection in two cats and the associated clinical characteristics. Importantly, we obtained SARS-CoV-2 genomes from one infected animal and characterized them as Alpha variants. This represents the first identification of the SARS-CoV-2 Alpha variant in an infected animal in France.

Identifiants

pubmed: 34578341
pii: v13091759
doi: 10.3390/v13091759
pmc: PMC8473452
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Université de Lyon
ID : ANR-16-IDEX-0005
Organisme : Agence Nationale de la Recherche
ID : ANR-RA-COVID-19

Références

Viruses. 2021 May 19;13(5):
pubmed: 34069453
N Engl J Med. 2020 Aug 6;383(6):592-594
pubmed: 32402157
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
J Med Virol. 2021 Feb;93(2):655-656
pubmed: 32797634
Nat Commun. 2020 Dec 4;11(1):6231
pubmed: 33277505
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Emerg Microbes Infect. 2020 Dec;9(1):2013-2019
pubmed: 32867625
J Small Anim Pract. 2021 May;62(5):336-342
pubmed: 33521974
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
Virulence. 2021 Dec;12(1):1597-1609
pubmed: 34125647
Emerg Infect Dis. 2020 Dec;26(12):3069-3071
pubmed: 32788033
Viruses. 2021 Jul 15;13(7):
pubmed: 34372585
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
Transbound Emerg Dis. 2021 May 6;:
pubmed: 33955193
Viruses. 2021 May 27;13(6):
pubmed: 34072254
Emerg Microbes Infect. 2021 Dec;10(1):376-383
pubmed: 33317424
PLoS One. 2021 Apr 28;16(4):e0250853
pubmed: 33909706
Emerg Infect Dis. 2021 May;27(5):1362-1370
pubmed: 33900184
Pathogens. 2021 Feb 23;10(2):
pubmed: 33672421
Viruses. 2021 Jul 22;13(8):
pubmed: 34452296
One Health. 2021 Dec;13:100295
pubmed: 34316508
Viruses. 2021 Apr 03;13(4):
pubmed: 33916759
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Microb Genom. 2017 Sep 14;3(10):e000132
pubmed: 29177090
Transbound Emerg Dis. 2021 Mar;68(2):973-976
pubmed: 32810370
Viruses. 2021 Apr 14;13(4):
pubmed: 33919936
One Health. 2021 Dec;13:100318
pubmed: 34462726
PLoS One. 2021 Mar 25;16(3):e0248578
pubmed: 33765012
Nature. 2003 Oct 30;425(6961):915
pubmed: 14586458
One Health. 2021 Jun;11:100192
pubmed: 33169106
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26382-26388
pubmed: 32994343
Int J Infect Dis. 2020 Jul;96:464-466
pubmed: 32470604

Auteurs

Emilie Krafft (E)

Campus Vétérinaire de Lyon, VetAgro Sup, Université de Lyon, 69280 Marcy-l'Etoile, France.

Solène Denolly (S)

CIRI-Centre International de Recherche en Infectiologie, Team EVIR, Université de Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, 69364 Lyon, France.

Bertrand Boson (B)

CIRI-Centre International de Recherche en Infectiologie, Team EVIR, Université de Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, 69364 Lyon, France.

Sophie Angelloz-Pessey (S)

Campus Vétérinaire de Lyon, VetAgro Sup, Université de Lyon, 69280 Marcy-l'Etoile, France.

Sophie Levaltier (S)

Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Normandie Université, UNICAEN, UNIROUEN, EA2656, 14032 Caen, France.
Laboratoire de Virologie, Centre Hospitalo-Universitaire, 14033 Caen, France.

Nicolas Nesi (N)

Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Normandie Université, UNICAEN, UNIROUEN, EA2656, 14032 Caen, France.

Sandrine Corbet (S)

Laboratoire de Virologie, Centre Hospitalo-Universitaire, 14033 Caen, France.

Bryce Leterrier (B)

Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Normandie Université, UNICAEN, UNIROUEN, EA2656, 14032 Caen, France.
Laboratoire de Virologie, Centre Hospitalo-Universitaire, 14033 Caen, France.

Matthieu Fritz (M)

Institut de Recherche pour le Développement (IRD), Maladies Infectieuses et Vecteurs, Ecologie, Génétique, Evolution et Contrôle (MIVEGEC) (Université de Montpellier-IRD 224-CNRS 5290), 34394 Montpellier, France.

Eric M Leroy (EM)

Institut de Recherche pour le Développement (IRD), Maladies Infectieuses et Vecteurs, Ecologie, Génétique, Evolution et Contrôle (MIVEGEC) (Université de Montpellier-IRD 224-CNRS 5290), 34394 Montpellier, France.

Meriadeg Ar Gouilh (MA)

Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Normandie Université, UNICAEN, UNIROUEN, EA2656, 14032 Caen, France.
Laboratoire de Virologie, Centre Hospitalo-Universitaire, 14033 Caen, France.
Institut de Recherche pour le Développement (IRD), Maladies Infectieuses et Vecteurs, Ecologie, Génétique, Evolution et Contrôle (MIVEGEC) (Université de Montpellier-IRD 224-CNRS 5290), 34394 Montpellier, France.

François-Loïc Cosset (FL)

CIRI-Centre International de Recherche en Infectiologie, Team EVIR, Université de Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, 69364 Lyon, France.

Angeli Kodjo (A)

Campus Vétérinaire de Lyon, VetAgro Sup, Université de Lyon, 69280 Marcy-l'Etoile, France.

Vincent Legros (V)

Campus Vétérinaire de Lyon, VetAgro Sup, Université de Lyon, 69280 Marcy-l'Etoile, France.
CIRI-Centre International de Recherche en Infectiologie, Team EVIR, Université de Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, 69364 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH